Blood pressure (BP) characteristics, such as central aortic pressure and arterial stiffness, independently predict cardiovascular events. The effects of pharmacologically dissimilar b-blockers on these properties have not been fully elucidated. Patients with essential hypertension and without significant concomitant cardiovascular disease were randomly assigned to controlled-release carvedilol, forcetitrated to 80 mg (n=22), or atenolol, force-titrated to 100 mg (n=19); each was given once daily for 4 weeks. Baseline characteristics were similar. At the end of week 4, atenolol and carvedilol reduced central and brachial systolic and diastolic BP to a similar extent. Central augmentation index was increased in atenolol-treated patients but not carvedilol-treated patients (atenolol 4.47% vs carvedilol )0.68%; P=.04). Mean augmented central aortic pressure increased slightly during atenolol treatment (+1.1 mm Hg) but decreased slightly during carvedilol treatment ()1.1 mm Hg), although the difference in these changes was not statistically significant (P=.23). Pulse pressure amplification was reduced more with atenolol at week 4 (atenolol )10.7% vs carvedilol )1.8%; P=.02). Therefore, we conclude that carvedilol results in more favorable pulse pressure amplification and augmentation index by increasing arterial compliance and reducing the magnitude of wave reflection, respectively, compared with atenolol. J Clin Hypertens (Greenwich). 2011;13:917-924. Ó2011 Wiley Periodicals, Inc.For many years, b-blockers were advocated as first-line therapy for most patients with hypertension. This class flourished during the past 50 years as the mainstay for the prevention and treatment of various cardiovascular disorders such as cardiac arrhythmias, myocardial infarction, and hypertension. Recently, the role of bblockers in uncomplicated hypertension has been questioned. Indeed, several recently updated guidelines have deemphasized their place in therapy.2,3 The reasons for this evolution are multifactorial, including publication of several clinical trials and meta-analyses which concluded that b-blockers are less effective than contemporary antihypertensives. [4][5][6][7] These observations could be ascribed to multiple factors including the fact that b-blockers exhibit an adverse metabolic profile, are poorly tolerated relative to newer antihypertensives, and have mismatched mechanisms of action with the pathophysiology of hypertension in elderly hypertensive patients. [8][9][10][11] Multiple recent studies suggest that blood pressure (BP) characteristics beyond the brachial cuff, such as central aortic pressure, wave reflection, and arterial stiffness, independently predict cardiovascular events, including all-cause and cardiovascular mortality, fatal and nonfatal coronary events, and fatal strokes in uncomplicated essential hypertension.12-15 These characteristics cannot be appreciated with conventional clinic BP measurements at the brachial artery. Radial artery tonometry and synthesis of the central aortic pressure wavefor...